We are pleased to share a new Genomic Press Interview with Dr. Gabriella Gobbi, CINP President Elect, Professor of Psychiatry at McGill University, and Canada Research Chair in Therapeutics for Mental Health.

From pioneering research on adolescent cannabis exposure and depression, to advancing novel melatonin receptor therapeutics, and early work on the neurobiology of psychedelics - Dr. Gobbi’s career exemplifies truly translational science.

As the first woman elected CINP President in its 70-year history, she reflects on her journey from Italy to Canada, the clinical insights that shaped her research, and her vision for a neuropsychopharmacology that remains deeply connected to patient care.

Read the full interview